205 related articles for article (PubMed ID: 30607538)
1. Can we rely on Danish? Real-world data on patients with nonischemic cardiomyopathy from the German Device Registry.
Frommeyer G; Andresen D; Ince H; Maier S; Stellbrink C; Kleemann T; Seidl K; Hoffmann E; Zrenner B; Hochadel M; Senges J; Eckardt L
Heart Vessels; 2019 Jul; 34(7):1196-1202. PubMed ID: 30607538
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.
El Moheb M; Nicolas J; Khamis AM; Iskandarani G; Akl EA; Refaat M
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012738. PubMed ID: 30537022
[TBL] [Abstract][Full Text] [Related]
3. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B
Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040
[TBL] [Abstract][Full Text] [Related]
4. Cardioverter-defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction.
Jilek C; Lewalter T; Pauschinger M; von Scheidt W; Frankenstein L; Pfister O; Hambrecht R; Bruder O; Brachmann J; Hartmann A; Strasser R; Hochadel M; Senges J
Clin Res Cardiol; 2020 Jan; 109(1):115-123. PubMed ID: 31236690
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy: data from the German device registry.
Frommeyer G; Reinke F; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Eckardt L
Clin Res Cardiol; 2020 Apr; 109(4):508-512. PubMed ID: 31367999
[TBL] [Abstract][Full Text] [Related]
6. Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.
Köbe J; Wasmer K; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Klein HU; Eckardt L
Int J Cardiol; 2013 Oct; 168(4):4184-90. PubMed ID: 23948108
[TBL] [Abstract][Full Text] [Related]
7. Selection and outcome of implantable cardioverter-defibrillator patients with and without cardiac resynchronization therapy: Comparison of 4384 patients from the German Device Registry to randomized controlled trials.
Köbe J; Willy K; Senges J; Hochadel M; Kleemann T; Spitzer SG; Andresen D; Jehle J; Steinbeck G; Szendey I; Butter C; Brachmann J; Hoffmann E; Eckardt L
J Cardiovasc Electrophysiol; 2022 Mar; 33(3):483-492. PubMed ID: 35028995
[TBL] [Abstract][Full Text] [Related]
8. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
[TBL] [Abstract][Full Text] [Related]
9. Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry.
Biffi M; Ammendola E; Menardi E; Parisi Q; Narducci ML; De Filippo P; Manzo M; Stabile G; Potenza DR; Zanon F; Quartieri F; Rillo M; Saporito D; Zacà V; Berisso MZ; Bertini M; Tumietto F; Malacrida M; Diemberger I
Europace; 2019 Oct; 21(10):1527-1536. PubMed ID: 31209482
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis.
Siddiqui WJ; Aggarwal S; Rafique M; Singh S; Kutalek S; Eisen HJ
Heart Fail Rev; 2018 Mar; 23(2):181-190. PubMed ID: 29380177
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Anantha Narayanan M; Vakil K; Reddy YN; Baskaran J; Deshmukh A; Benditt DG; Adabag S
JACC Clin Electrophysiol; 2017 Sep; 3(9):962-970. PubMed ID: 29759721
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
[TBL] [Abstract][Full Text] [Related]
13. Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry.
El-Battrawy I; Kovacs B; Dreher TC; Klein N; Rosenkaimer S; Röger S; Kuschyk J; Saguner AM; Kowitz J; Erath JW; Duru F; Akin I
Sci Rep; 2022 Feb; 12(1):3203. PubMed ID: 35217697
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of MADIT-II Risk Stratification Score Among Nationwide Registry of Heart Failure Patients With Primary Prevention Implantable Cardiac Defibrillators or Resynchronization Therapy Devices.
Rav-Acha M; Wube O; Brodie OT; Michowitz Y; Ilan M; Ovdat T; Klempfner R; Suleiman M; Goldenberg I; Glikson M
Am J Cardiol; 2024 Jan; 211():17-28. PubMed ID: 37879381
[TBL] [Abstract][Full Text] [Related]
15. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
Stavrakis S; Asad Z; Reynolds D
J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
[TBL] [Abstract][Full Text] [Related]
16. Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study.
Singh B; Hsieh YC; Liu YB; Lin KH; Joung B; Rodriguez DA; Chasnoits AR; Huang D; Zhang S; O'Brien JE; Lexcen DR; Cerkvenik J; Van Dorn B; Ching CK
Indian Heart J; 2023; 75(2):115-121. PubMed ID: 36736459
[TBL] [Abstract][Full Text] [Related]
17. [ECG score to predict ICD therapies in patients with nonischemic cardiomyopathy and primary prophylactic CRT-D].
Grett M; Christ M; Röing Gen Nölke JP; Trappe HJ
Herzschrittmacherther Elektrophysiol; 2017 Mar; 28(1):48-53. PubMed ID: 28204917
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic implantation of cardioverter defibrillators in idiopathic nonischemic cardiomyopathy for the primary prevention of death: a narrative review.
Cevik C; Nugent K; Perez-Verdia A; Fish RD
Clin Cardiol; 2010 May; 33(5):254-60. PubMed ID: 20513063
[TBL] [Abstract][Full Text] [Related]
19. Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy.
Boas R; Sappler N; von Stülpnagel L; Klemm M; Dixen U; Thune JJ; Pehrson S; Køber L; Nielsen JC; Videbæk L; Haarbo J; Korup E; Bruun NE; Brandes A; Eiskjær H; Thøgersen AM; Philbert BT; Svendsen JH; Tfelt-Hansen J; Bauer A; Rizas KD
Circulation; 2022 Mar; 145(10):754-764. PubMed ID: 34889650
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
